Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionRise in essential drug prices may not boost pharma earnings significantly

    Rise in essential drug prices may not boost pharma earnings significantly

    Raw material inflation continues to be a problem for drug manufacturers, eroding the benefit from an increase in the prices of essential drugs

    R. Sree Ram
    March 29, 2022 / 11:12 IST
    • PRO Panorama

      Moneycontrol Pro Panorama | Of balance sheets and innovation

      Nov 28, 2025 / 03:03 PM IST

      Moneycontrol Pro Panorama November 28 edition: India’s employment paradox decoded, Gold is glittering and equity is holding up, ...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts